Osalmid Inhibits the Progression of Lung Adenocarcinoma and Sensitizes It to EGFR-TKIs: A Preclinical and Translational Study

被引：0
|
作者：
Wu, L. -L. [1 ]
Jiang, W. -M. [1 ]
Wang, R. -R. [2 ]
Xie, D. [2 ]
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[2] Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.03I.14
引用
收藏
页码：S315 / S315
页数：1
相关论文
共 50 条
  • [11] Bone metastasis reduces responsiveness to EGFR-TKIs in patients with EGFR-mutated advanced lung adenocarcinoma
    Zheng, X.
    Huang, C.
    Lin, G.
    ANNALS OF ONCOLOGY, 2018, 29
  • [12] Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs
    Lin, Jessica J.
    Cardarella, Stephanie
    Lydon, Christine A.
    Dahlberg, Suzanne E.
    Jackman, David M.
    Jaenne, Pasi A.
    Johnson, Bruce E.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : 556 - 565
  • [13] The Incidence Rate of Radiation Pneumonitis Observed in Patients Treated with Thoracic Radiotherapy and Concurrent First-Generation EGFR-TKIs, Second-Generation EGFR-TKIs or Third-Generation EGFR-TKIs in Advanced Lung Adenocarcinoma
    Mu, F.
    Fan, B.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E382 - E383
  • [14] TTF-1 Expression as a Predictor of Response to EGFR-TKIs in Patients with Lung Adenocarcinoma
    Syrigos, Kostas
    Sarris, Evangelos
    Kotteas, Ilias
    Fotopoulos, Georgios
    Vamvakaris, Loannis
    Trigidou, Rodoula
    Grapsa, Dimitra
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1197 - S1197
  • [15] Downregulation of caveolin-1 increased EGFR-TKIs sensitivity in lung adenocarcinoma cell line with EGFR mutation
    Cui, Yujie
    Zhu, Tienian
    Song, Xuejing
    Liu, Jiankun
    Liu, Shuang
    Zhao, Ruijing
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (01) : 733 - 739
  • [16] A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs
    Park, Ji Soo
    Hong, Min Hee
    Chun, You Jin
    Kim, Hye Ryun
    Cho, Byoung Chul
    LUNG CANCER, 2019, 134 : 46 - 51
  • [17] Occurrence of HER2 amplification in EGFR-mutant lung adenocarcinoma with acquired resistence to EGFR-TKIs
    Altavilla, Giuseppe
    Arrigo, Carmela
    Tomasello, Chiara
    Santarpia, Mariacarmela
    Mondello, Patrizia
    Benecchi, Sara
    Pitini, Vincenzo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [18] Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs
    Gu, Zhenbang
    Huang, Peng
    Zhao, Jiali
    Luo, Chen
    Liao, Lingmin
    Liu, Anwen
    Huang, Long
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (11) : 1979 - 1986
  • [19] Acquired Resistance to EGFR-TKIs in EGFR-Mutant Lung Adenocarcinoma Among Hispanics (RBIOP-CLICaP)
    Cardona, Andres F.
    Arrieta, Oscar
    Zapata, Martin I.
    Rojas, Leonardo
    Wills, Beatriz
    Carranza, Hernan
    Reguart, Noemi
    Vargas, Carlos
    Otero, Jorge
    Corrales-Rodriguez, Luis
    Martin, Claudio
    Archila, Pilar
    Cuello, Mauricio
    Ortiz, Carlos
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S168 - S168
  • [20] Nimotuzumab Plus Chemotherapy in the Posterior Line Therapy of EGFR-TKIs Resistant Lung Adenocarcinoma: A Case Series Study
    Lu, K.
    Zhang, M.
    Wang, Q.
    Sun, A.
    Xiang, Y.
    Liu, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S628 - S628
12345